首页 | 本学科首页   官方微博 | 高级检索  
检索        

血府逐瘀丸对动脉粥样硬化血瘀征象及危险因素影响的研究
引用本文:李艳梅,陈可冀,史载祥,张铁忠.血府逐瘀丸对动脉粥样硬化血瘀征象及危险因素影响的研究[J].中国中西医结合杂志,1998,18(2):71-73.
作者姓名:李艳梅  陈可冀  史载祥  张铁忠
作者单位:天津中医学院第一附属医院!天津300193中国中医研究院西苑医院(李艳梅),中国中医研究院西苑医院(陈可冀),中日友好医院(史载祥,张铁忠)
摘    要:目的:观察血府逐瘀丸对动脉粥样硬化血瘀征象和危险因素的影响。方法:将57例患者随机分为血府逐瘀丸组(30例)和阿斯匹林组(27例),分别给予血府逐瘀丸口服,每次6g,每日3次。小剂量阿斯匹林每桨40mg,每日1次,治疗1个月。结果:血府逐瘀丸能够改善动脉粥样硬化患者的血瘀证候(P〈0.01),降低体内脉粥样硬化危险因素--高血胆固醇(P〈0.05)、氧化低密度脂蛋白(P〈0.05)和血浆内α-颗粒

关 键 词:动脉粥样硬化  血瘀证  血府逐瘀丸  危险因素

Effect of Xuefu Zhuyu Pill on Blood Stasis Syndrome and Risk Factor of Atherosclerosis
Authors:Li Yanmei  Chen Keji  Shi Zaixiang  
Institution:Xiyuan Hospital China Academg of TCM, Beijing 100091.
Abstract:To observe the effect of Xuefuzhuyu Pill (XFZYP) on blood stasis syndrome and risk factor of atherosclerosis. Methods: Fifty-seven patients of atherosclerosis were randomly divided into XFZYP group (30 cases) and aspirin group (27 cases) treated with XFZYP (6g, three times daily) and aspirin (40mg per day) oral taken respectively for one month. Results: XFZYP could improve blood stasis syndrome of patients (P<0.01) and reduced the level of risk factor of atherosclerosis, including high blood cholesterol (P<0.01), oxidation of low density lipoprotein (P<0.05) and plasma granule membrane protein Q (P<0.01). Conclusion: XFZYP is beneficial to retard the progress of atherosclerosis.
Keywords:
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国中西医结合杂志》浏览原始摘要信息
点击此处可从《中国中西医结合杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号